SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026076
Filing Date
2017-05-10
Accepted
2017-05-10 16:33:08
Documents
65
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v464152_10q.htm 10-Q 350331
2 EXHIBIT 10.1 v464152_ex10-1.htm EX-10.1 121884
3 EXHIBIT 31.1 v464152_ex31-1.htm EX-31.1 8685
4 EXHIBIT 31.2 v464152_ex31-2.htm EX-31.2 7660
5 EXHIBIT 32.1 v464152_ex32-1.htm EX-32.1 4137
  Complete submission text file 0001144204-17-026076.txt   5058260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT icpt-20170331.xml EX-101.INS 1544550
7 XBRL TAXONOMY EXTENSION SCHEMA icpt-20170331.xsd EX-101.SCH 38023
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20170331_cal.xml EX-101.CAL 45939
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20170331_def.xml EX-101.DEF 101321
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20170331_lab.xml EX-101.LAB 294270
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20170331_pre.xml EX-101.PRE 248216
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 17830831
SIC: 2834 Pharmaceutical Preparations